Effects of Insulin Aspart 30 versus Glimepiride on B Islet Cell Function in Patients with Newly Diagnosed Type 2 Diabetes / 中国药房
China Pharmacy
; (12)2005.
Article
en Zh
| WPRIM
| ID: wpr-530704
Biblioteca responsable:
WPRO
ABSTRACT
OBJECTIVE:To discuss the effects of different intensive treatment on B islet cell function in patients with newly diagnosed type 2 diabetes. METHODS: 54 patients who had been newly diagnosed as having type 2 diabetes were randomly assigned to receive Insulin aspart 30 or Glimepiride combined with Metformin (oral hypoglycemic agent). The blood glucose, glycosylated hemoglobin (HbA1c), and B islet cell function in two groups before and after treatment were followed. RESULTS: After treatment, blood glucose and glycosylated hemoglobin (HbA1c) in both group lowered significantly (P
Texto completo:
1
Base de datos:
WPRIM
Tipo de estudio:
Diagnostic_studies
Idioma:
Zh
Revista:
China Pharmacy
Año:
2005
Tipo del documento:
Article